Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
Human immunodeficiency virus type 1 (HIV-1) infection causes acquired immune deficiency syndrome (AIDS), a global epidemic for more than three decades. HIV-1 replication is primarily controlled through antiretroviral therapy (ART) but this treatment does not cure HIV-1 infection. Furthermore, there...
Main Authors: | Zhiqing Zhang, Shaowei Li, Ying Gu, Ningshao Xia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/11/1901 |
Similar Items
-
The expanding array of HIV broadly neutralizing antibodies
by: Laura E. McCoy
Published: (2018-10-01) -
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
by: Matthew S. Parsons, et al.
Published: (2018-08-01) -
Cross-reactive broadly neutralizing antibodies: timing is everything
by: Zelda eEuler, et al.
Published: (2012-07-01) -
Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies
by: A. N. Chikaev, et al.
Published: (2021-09-01) -
Broad Neutralization as a Byproduct of Antibody Maturation during HIV-1 Infection: a Personal Perspective
by: Feng Gao
Published: (2016-07-01)